NCT02599870View on ClinicalTrials.gov

Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures

NATerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Acute PainSurgery

Interventions

GENETIC

NeuroIDgenetix Test Panel

The NeuroIDgenetix Test Panel is used to make recommendations on post-operative pain medication therapy that may be impacted by the genetic background of the patient.

Trial Locations (1)

70121

Ochsner Health System, New Orleans